Skip to main content
Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0082
+0.0001 (1.23%)
At close: Mar 6, 2026

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $5.11M in the twelve months ending September 30, 2025, down -1,503.44% year-over-year. In the year 2024, Petros Pharmaceuticals had annual revenue of $5.11M, down -12.20%.

Revenue
5.11M
Revenue Growth
-1,503.44%
P/S Ratio
0.07
Revenue / Employee
284.00K
Employees
18
Market Cap
347.45K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.11M-710.35K-12.20%
Dec 31, 20235.82M-169.67K-2.83%
Dec 31, 20225.99M-1.82M-23.29%
Dec 31, 20217.81M-1.75M-18.29%
Dec 31, 20209.56M-6.02M-38.63%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Stemtech 3.73M
Ecofibre 17.56M
Branded Legacy 87.65K
Fifty 1 Labs 4.08M
Cannabis Strategic Ventures 14.60M
Resonate Blends 2.23M
Sky Century Investment 89.49K
ViaDerma 44.69K
Revenue Rankings

Petros Pharmaceuticals News

More News